Arizona Oncology Associates PC
Arizona Oncology Associates PC was paid $13.89M by Medicaid between Jan 2018 and Dec 2024, across 87 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 28% of everything it billed.
33Billing provider infoARIZONA ONCOLOGY ASSOCIATES PC
TUCSON, AZ 85712
TUCSON, AZ 85712
33aNPI1578587671assigned 07/26/2006
33bProvider typeSpecialist
28Total paid$13.89M
24GClaims219,178
24DCodes billed87
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Specialist providers in Arizona
Rank by total paid#2 of 179
Median peer was paid$112K
This provider vs. median124×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 50,875 | $3.47M | |
| 2019 | 46,753 | $2.81M | |
| 2020 | 32,657 | $2.19M | |
| 2021 | 35,555 | $2.19M | |
| 2022 | 22,004 | $1.22M | |
| 2023 | 17,806 | $1.24M | |
| 2024incomplete | 13,528 | $768K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 28% | 71,130 | 62,983 | $3.89M |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 15% | 22,897 | 15,143 | $2.08M |
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 10% | 6,500 | 1,159 | $1.42M |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 7.6% | 13,941 | 11,426 | $1.05M |
| J2505 | Injection, pegfilgrastim, 6 mg | 4.8% | 187 | 132 | $673K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 4.7% | 18,325 | 16,603 | $660K |
| 77014 | 3.5% | 7,025 | 1,293 | $480K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 3.2% | 4,684 | 4,554 | $440K |
| 78815 | Positron emission tomography (PET) for limited area imaging | 2.0% | 412 | 382 | $279K |
| J2469 | Injection, palonosetron hcl, 25 mcg | 2.0% | 2,686 | 1,695 | $274K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.8% | 1,876 | 1,785 | $251K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.7% | 11,825 | 7,443 | $240K |
75 more codes
| J1453 | Injection, fosaprepitant, 1 mg | 1.4% | 1,222 | $193K |
| G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation agreement | 1.4% | 1,055 | $191K |
| 77427 | 1.3% | 1,561 | $187K | |
| 96367 | 1.3% | 5,509 | $179K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 1,711 | $136K |
| J0897 | Injection, denosumab, 1 mg | <1% | 113 | $128K |
| 77336 | <1% | 1,756 | $87K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 1,284 | $83K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 7,367 | $80K |
| 51798 | <1% | 9,435 | $78K | |
| 99223 | Prolong inpt eval add15 m | <1% | 643 | $73K |
| 52000 | <1% | 612 | $73K | |
| 99205 | Prolong outpt/office vis | <1% | 486 | $59K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 914 | $49K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 3,038 | $46K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 1,113 | $45K |
| 96417 | <1% | 771 | $43K | |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | <1% | 404 | $31K |
| 77301 | <1% | 29 | $29K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 57 | $24K |
| 77300 | <1% | 192 | $22K | |
| 77334 | <1% | 164 | $21K | |
| 52356 | <1% | 68 | $21K | |
| 36591 | <1% | 1,017 | $19K | |
| 77338 | <1% | 74 | $18K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,855 | $18K |
| G6012 | Radiation treatment delivery, 3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev | <1% | 82 | $17K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 261 | $16K |
| 96415 | <1% | 478 | $15K | |
| 77280 | <1% | 86 | $14K | |
| 77263 | <1% | 102 | $12K | |
| 50590 | <1% | 19 | $11K | |
| 51784 | <1% | 356 | $11K | |
| G6013 | Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev | <1% | 62 | $10K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 135 | $10K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 8,382 | $9K |
| G6017 | Intra-fraction localization and tracking of target or patient motion during delivery of radiation therapy (eg,3d positional tracking, gating, 3d surface tracking), each fraction of treatment | <1% | 117 | $9K |
| J3490 | Unclassified drugs | <1% | 709 | $8K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 362 | $8K |
| 96523 | <1% | 264 | $6K | |
| G6002 | Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | <1% | 83 | $6K |
| 51728 | <1% | 26 | $6K | |
| 87481 | <1% | 55 | $5K | |
| 74420 | <1% | 272 | $5K | |
| 76857 | <1% | 160 | $4K | |
| 96411 | <1% | 96 | $4K | |
| J9190 | Injection, fluorouracil, 500 mg | <1% | 77 | $4K |
| J1750 | Injection, iron dextran, 50 mg | <1% | 12 | $4K |
| 87653 | <1% | 71 | $2K | |
| 87640 | <1% | 71 | $2K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 71 | $2K |
| J0640 | Injection, leucovorin calcium, per 50 mg | <1% | 55 | $2K |
| 77470 | <1% | 30 | $2K | |
| 91122 | <1% | 15 | $2K | |
| 51797 | <1% | 29 | $2K | |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 28 | $1K |
| 52332 | <1% | 17 | $1K | |
| J1626 | Injection, granisetron hydrochloride, 100 mcg | <1% | 254 | $1K |
| 46600 | <1% | 13 | $1K | |
| 97750 | <1% | 49 | $1K | |
| 96368 | <1% | 70 | $986.98 | |
| 99442 | <1% | 15 | $896.35 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 359 | $499.36 |
| 57420 | <1% | 22 | $496.45 | |
| 51700 | <1% | 20 | $398.58 | |
| 97032 | <1% | 47 | $366.76 | |
| 51741 | <1% | 41 | $299.97 | |
| 96127 | <1% | 67 | $281.30 | |
| 81002 | <1% | 153 | $258.02 | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 14 | $250.34 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 409 | $221.48 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 65 | $125.25 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 14 | $101.31 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 14 | $53.71 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 31 | $18.69 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGIN, ROBERT (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Littleton Pediatric Medical Center | Highlands Ranch, CO | $1.74M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.